C-Rad AB

GREAT INTEREST FOR THE NEW C-RAD PRODUCTS PRESENTED AT THE ANNUAL EUROPEAN ESTRO MEETING

Pressmeddelande   •   Sep 29, 2008 10:54 CEST



C-RAD AB with its three fully owned subsidiaries develops new and innovative solutions for the use in advanced radiation therapy. The company attended and exhibited at the ESTRO annual meeting 14 to 17 September 2008. The meeting this year took place in Gothenburg, Sweden. The customers showed great interest for the Sentinel system with new functionality and the announcement of the GEMini detector system for use in radiation therapy.

The annual oncology meeting in Europe, ESTRO is one of the major events within the radiation therapy industry. The meeting this year took place 14 to 17 September 2008 in Gothenburg.

The laser scanner system, SentinelTM, was demonstrated with full functionality for patient positioning and the newly released motion detection functionality. The combined positioning and motion detection functionality in place offers a streamlined workflow for the radiation therapy clinic. The motion detection functionality offers a new dimension of accuracy for intra fractional movements during treatment. Furthermore a first prototype for so called respiratory gating was demonstrated.

A first version of the detector system GeminiTM for use in radiation therapy was demonstrated. The detector system with its unique technology and outstanding performance was presented to both representatives of all major companies working in radiation therapy and attendees of the conference.

Erik Hedlund, CEO, C-RAD AB:
- The great and increasing interest at ESTRO for the Sentinel and GEMini systems confirms the developments of the C-RAD group. Representatives of a number of well recognized radiation therapy clinics visited C-RAD during the show. Important meetings with key players in the industry took place.

2008-09-29

For further information:
Erik Hedlund, CEO C-RAD AB,
Telefon 018 - 66 69 31,
E-post erik.hedlund@c-rad.se

The following documents can be retrieved from beQuoted
C-RAD Pressrelease 2008-09-29 (English).pdf

Mer information från beQuoted
Nyhetssida C-RAD

About C-RAD AB
C-RAD develops new and innovative solutions for the use in advanced radiation therapy. The company group of C-RAD offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB. C-RAD Imaging AB is located in Östersund while the other companies are located in Uppsala. Number of employees are currently 19 people. The activities in C-RAD AB originates in research and development at the Karolinska Institutet in Solna and the The Royal Institute of Technology in Stockholm. Sales of the company's first product, the C-RAD SentinelTM, started during autumn 2006. A co-operation agreement has been signed with the German company LAP. Distribution agreements has also been established for USA, Japan, Korea, China and Italy. C-RAD AB is a listed company on Aktietorget since 23 July 2007.